A. SCOTT ANDERSON - 06 Mar 2023 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
Director
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Issuer symbol
MMSI
Transactions as of
06 Mar 2023
Net transactions value
-$563,160
Form type
4
Filing time
08 Mar 2023, 11:49:50 UTC
Previous filing
02 Mar 2023
Next filing
09 May 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Options Exercise $94,000 +5,000 +11% $18.80 52,135 06 Mar 2023 Direct
transaction MMSI Common Stock, No Par Value Options Exercise $344,000 +10,000 +19% $34.40 62,135 06 Mar 2023 Direct
transaction MMSI Common Stock, No Par Value Sale $1,001,160 -15,000 -24% $66.74 47,135 06 Mar 2023 Direct F1
transaction MMSI Common Stock, No Par Value Gift $0 -3,000 -6.4% $0.000000 44,135 07 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Options Exercise $0 -5,000 $0.000000 $0 06 Mar 2023 Common Stock $5,000 $18.80 Direct F2
transaction MMSI Non-qualified stock options (right to buy) Options Exercise $0 -10,000 -100% $0.000000* 0 06 Mar 2023 Common Stock 10,000 $34.40 Direct F3
holding MMSI Non-qualified stock options (right to buy) 25,000 06 Mar 2023 Common Stock 25,000 $50.50 Direct F4
holding MMSI Non-qualified stock options (right to buy) 13,750 06 Mar 2023 Common Stock 13,750 $52.17 Direct F5
holding MMSI Non-qualified stock options (right to buy) 7,500 06 Mar 2023 Common Stock 7,500 $52.17 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.20 to $67.00 inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2 Becomes exercisable in equal annual installments of 20% commencing 05/26/2017.
F3 Becomes exercisable in equal annual installments of 20% commencing 05/24/2018.
F4 Becomes exercisable in equal annual installments of 20% commencing 06/07/2019.
F5 Becomes exercisable in equal annual installments of 33% commencing 05/24/2020.
F6 Becomes exercisable in equal annual installments of 33% commencing 05/31/2020.